
Journal of Medicinal Chemistry p. 593 - 599 (1991)
Update date:2022-08-04
Topics:
Kurokawa, Mikio
Sato, Fuminori
Hatano, Naonobu
Honda, Yayoi
Uno, Hitoshi
A series of 11-<(ω-aminoalkanoyl)amino>-6,6a,7,8,9,10,10a,11-octahydrodibenzothiepin derivatives were prepared and found to be structurally new class of calcium antagonists.The structure-activivty relationship studies indicated that the optimum was (6aR*,10aR*,11R*)-11-<<4-<-<4-(4-fluorophenyl)-1-piperazinyl>butyryl>amino>-6,6a,7,8,9,10,10a,11-octahydrodibenzothiepin (31, pA2 8.16), which was superior to diltiazem (pA2 7.42) in calcium antagonistic activity.Compound 31 showed antihypertensive activity in anesthetized rats, without a significant effect on the heart rate.It had also antianginal effects in vasopressin-induced ST-elevation testings in rats.These potencies of 31 were essentially equal to those of diltiazem.
View MoreSynochem Ingredients Corp., Ltd.
Contact:+86-512-5636 2180
Address:Zhangjiagang Free Trade Zone
MedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Cerametek Materials(ShenZhen)Co., Ltd.
Contact:+86-755-2324.2554
Address:A3-#9, YongChuan Street, Suite 501
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Doi:10.1016/j.tetlet.2021.153204
(2021)Doi:10.1021/ic200706e
(2011)Doi:10.1016/j.ejmech.2011.02.069
(2011)Doi:10.1080/00397911.2010.494817
(2011)Doi:10.1021/om200323c
(2011)Doi:10.1016/j.bmcl.2011.03.031
(2011)